Epithalon Where to Buy
Six checks that fit into a single evening, in the order they take, and then one real listing scored against every one of them.
Epithalon where to buy is really a question about paperwork, and the useful version of it fits into one evening: six checks, run in order, before any card details are typed. Nothing here is a vendor roundup.
The compound in question is a synthetic tetrapeptide of four residues, Ala-Glu-Asp-Gly, catalogued by PubChem as CID 219042 with the formula C14H22N4O9 and a molecular weight of 390.35. Everything described on this page is research material for laboratory use and not for human consumption, and the links to the supplier below are affiliate links.
The listing scored at the end of this page is this one, so it is worth having open while the criteria go past.
Where the order actually gets placed
Ascension Peptides, Epithalon
US-based and third-party tested. Enter the code on the payment step and the vial halves before you confirm.
The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.
- Two batch certificates per lot
- Shipping free over $250
- Out the door same day if you order before 2pm CST
Everything here is research material for laboratory use, not for human consumption. Affiliate links, so we may earn a commission at no cost to you. Prices last checked August 23, 2026.
Epithalon where to buy: the six checks, in the order they take
The order matters because the early checks are fast and disqualifying, and the later ones only reward you if the early ones passed.
Check one: does a certificate exist, and does it name a batch
Two minutes. Open the product page and look for a document, not a claim. Body copy reading "third-party tested" is not a test result, and neither is a laboratory logo.
The document has to carry a batch or lot number, and that number has to be the one printed on the vial that arrives. This is the check that eliminates most of the market, because the common substitute is a single product-level PDF republished for every shipment across two years of stock. It describes some material that once existed. It cannot describe yours.
Check two: purity, and the specification it was measured against
Three minutes, and it is the specification column that takes them.
A bare percentage is decoration. A purity result becomes information when it sits next to the threshold the seller committed to and the method used to get there. Reversed-phase HPLC on a C18 column with diode-array detection at 214 nm is the ordinary method for a peptide this size, and a certificate that names it is telling you something a certificate reporting a naked number is not.
Check three: identity confirmation
One minute, and it is the check people skip most often.
Purity answers how much of the powder is one substance. Identity answers whether that substance is the one on the label. They are different questions, and a certificate can pass the first while never asking the second. Mass spectrometry, usually written as LC-MS on these documents, is what answers it. On a four-residue peptide there is no exotic chemistry involved, which is exactly why its absence is telling.
Check four: endotoxin and sterility, if anything is ever injected
Five minutes, and this is where the regulatory concern actually lives.
FDA's published position on epitalon is that compounded drugs containing it may pose a risk of immunogenicity for certain routes of administration because of the potential for aggregation and peptide-related impurities. Aggregation and impurities are a purity and identity question. Immunogenicity on an injected route is, in large part, an endotoxin question. Look for a bacterial endotoxin result reported against a stated limit, and a microbial screen reported as growth or no growth. A test named without a limit is a claim wearing a lab coat.
Check five: net content, actually measured
Two minutes, and it is the one almost nobody runs.
The number on the label is a target. The number in the vial is a measurement, and the two are only the same by luck. Filling equipment has tolerances, sellers set those tolerances in their specifications, and a certificate that reports assayed quantity is publishing where the lot landed inside them. A certificate that stays silent on net content is asking you to accept the label as though it were a result.
Check six: where the vial physically sits when you pay
Ten minutes, spread across the shipping page and the checkout.
A seller holding domestic stock states a dispatch cutoff as a clock time, because that is a promise it controls. A seller without domestic stock states a handling window in business days, because that is the only promise it can make. The distinction decides your elapsed time, and it quietly decides your recourse too, since a business inside your jurisdiction is one a card issuer and a consumer regulator can both reach.
What the checks look like run against one real listing
Ascension publishes a single certificate for its Epithalon, and it is worth reading rather than trusting, so here is what it contains.
The report is numbered KVR-2026-A36FF4, comes from Kovera Labs, was certified on 05/23/2026, and covers batch 15-05260628 of a lyophilised powder labelled 10 mg with the formula C14H22N4O9 and CAS number 307297-39-8.
Check one passes: there is a batch number. Check two passes at 99.312% purity against a specification of 98 percent or better, by RP-HPLC on a C18 column with detection at 214 nm. Check three passes with identity confirmed by LC-MS. Check four passes twice, with an endotoxin safety screen returning PASS against a limit of 0.5 EU/mL and a microbial sterility screen returning no growth, plus heavy metals screening that came back negative for arsenic, cadmium, lead and mercury. The report also prints an access code for the laboratory's own verification portal at koveralabs.com/verify, which is a small thing that most certificates in this market do not offer at all.
Check five is the interesting one. Net content is reported as 9.64 mg against a 10 mg label, with the specification written as 10 mg plus or minus 10 percent. That is inside tolerance and under the label, and it is the number this whole page exists to point at.
Check six passes on the shipping terms: same-day dispatch on orders placed before 2pm CST, which only domestic inventory supports.
The fill weight, and the arithmetic nobody flatters
The vial lists at $50.00, reduced from $69.99, and falls to $25.00 with the code PEPTIDEDECK. On the label weight that is $2.50 per milligram. On the 9.64 mg the laboratory actually measured, it is $2.59 per milligram.
Both figures are true and the second one is the one that describes that batch. Publishing only the first would be the ordinary move, and the reason to publish both is that the seller published the underlying number in the first place. A company that prints a fill weight slightly against its own interest has told you something about how it handles documents that no marketing sentence can tell you.
It is worth holding this at the right size. It is a genuine underfill inside a stated tolerance, not a scandal, and the direction reverses lot to lot. What matters is the measuring and the showing, not which side of the label the result landed on.
Quantity tiers of 3, 5 or 10 vials take 3%, 5% or 10% off the list price, and nothing published says the code stacks with them, so treat that as untested rather than as a discount you have. Free shipping starts at $250, which one discounted vial does not reach.
What six passed checks still do not buy you
A clean certificate is a statement about a batch of powder. It is not a statement about what the substance does in a person, and the distinction matters more here than for most compounds, because Epithalon is marketed on telomere and longevity claims that rest largely on Russian-language work from one research group in St Petersburg. Reporting that those claims exist is accurate. Treating them as established is not, and no certificate moves that line by a millimetre.
The regulatory position is worth stating precisely, because it is misdescribed constantly. Epitalon, which is how FDA and PubChem spell it, is on no current FDA category list. It was nominated as a bulk drug substance, sat in category 2 under the interim policies, and the nomination was then withdrawn, so it now appears in FDA's table of substances nominated but withdrawn on a page current as of 04/22/2026. It is not banned, it was never evaluated to a conclusion, and it has no FDA approval for anything. It is also not a component of an approved drug and has no applicable USP monograph, which together mean a 503A pharmacy has no lawful route to compound it under 21 CFR 216.23.
The last thing six checks cannot do is repeat themselves. A certificate covers the lot it names. The next lot is a new document, and a seller that stops publishing them has quietly failed check one without changing a word on its product page.
Common questions
Common Concerns
How long do the six checks actually take?expand_more
Why does a vial that assays under its label read as a good sign?expand_more
Is Epithalon the same thing as Epitalon?expand_more
Do the certificate results say the substance is safe?expand_more
What single omission should end a purchase?expand_more
Does a longevity clinic count as a source worth checking?expand_more
Keep exploring
The same evening of checking, run against a compound sitting in the identical withdrawn-nomination position on FDA's page, is what to verify on a Semax vial before ordering. For a substance sold to an overlapping longevity audience where a genuine clinic channel exists alongside the vials, the NAD+ version of grade-first buying shows how the checks change when a chair and an appointment are on the table. And the BPC-157 ranking scored on paper, time and price is what happens when the same criteria are weighted and turned into an order of preference.
Sources
- Certificate of Analysis, Epithalon 10 mg, batch 15-05260628 (Kovera Labs, report KVR-2026-A36FF4)
- FDA: Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks
- FDA: Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
- PubChem: Epitalon, CID 219042
- 21 CFR 216.23: Bulk drug substances that can be used to compound drug products under section 503A